Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Dimitri Semizarov"'
Autor:
Dwaipayan Mukherjee, Michelle Collins, Douglas E. Dylla, Jatinder Kaur, Dimitri Semizarov, Anthony Martinez, Brian Conway, Tipu Khan, Nael M. Mostafa
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 8, Pp 2057-2070 (2023)
Abstract Introduction An unsafe injection practice is one of the major contributors to new hepatitis C virus (HCV) infections; thus, people who inject drugs are a key population to prioritize to achieve HCV elimination. The introduction of highly eff
Externí odkaz:
https://doaj.org/article/e796bef6bd3e4e6ca9343e67f5fad543
Autor:
Dimitri Semizarov, Rick Lesniewski, Guido Sauter, Stephen K. Tahir, Gang Wang, Mark G. Anderson, Charles Van Sant, Edward T. Olejniczak
Supplementary Table S3 from Integrative Genomic Analysis of Small-Cell Lung Carcinoma Reveals Correlates of Sensitivity to Bcl-2 Antagonists and Uncovers Novel Chromosomal Gains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f070759111d30eeaa00eabf58e85394
https://doi.org/10.1158/1541-7786.22520652
https://doi.org/10.1158/1541-7786.22520652
Autor:
Alexander R. Shoemaker, Eric F. Johnson, Joel Leverson, Yan Luo, Vincent L. Giranda, Saul Rosenberg, Thomas Penning, Gui-dong Zhu, Joann Palma, Loren Lasko, Lisa Roberts, Thomas McGonigal, Gang Wang, Dimitri Semizarov, Yan Shi, Mark Anderson, Edward K. Han, Xuesong Liu
Supplementary Data from Acquired Resistance to Combination Treatment with Temozolomide and ABT-888 Is Mediated by Both Base Excision Repair and Homologous Recombination DNA Repair Pathways
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7adbcf3cdc98e10819a2cee5137aaf0
https://doi.org/10.1158/1541-7786.22521748
https://doi.org/10.1158/1541-7786.22521748
Supplementary Figure 2D-E from A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4459773f3393f00174371718092acf8c
https://doi.org/10.1158/1535-7163.22484751.v1
https://doi.org/10.1158/1535-7163.22484751.v1
Evasion of apoptosis is a known feature of cancer cells. One mechanism of deregulating the apoptotic pathway is through overexpression of antiapoptotic BCL2 family members. ABT-263 (navitoclax) is a first-in-class BCL2 family inhibitor that restores
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7523616333f452ffe6b7aed66b71d059
https://doi.org/10.1158/1535-7163.c.6531561
https://doi.org/10.1158/1535-7163.c.6531561
Supplementary Figure 2A-C from A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::798caa87e5b9a41a8df76d2ec625fd7e
https://doi.org/10.1158/1535-7163.22484754.v1
https://doi.org/10.1158/1535-7163.22484754.v1
Supplementary Figure 1 from A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59e94a5af2bf84008270fdc190d79b84
https://doi.org/10.1158/1535-7163.22484757
https://doi.org/10.1158/1535-7163.22484757
Supplementary Figure Legends from A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afef2177199aa8e2760ed0e096453e2f
https://doi.org/10.1158/1535-7163.22484742.v1
https://doi.org/10.1158/1535-7163.22484742.v1
Supplementary Figure 4 from A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d54807b054785f7165d8aafe1e32a0d
https://doi.org/10.1158/1535-7163.22484745.v1
https://doi.org/10.1158/1535-7163.22484745.v1
Autor:
Christopher J. Byrne, Andrew Radley, Sarah K. Inglis, Lewis Beer, Nicki Palmer, Minh Duc Pham, Kate Allardice, Huan Wang, Emma Robinson, Monika Hermansson, Dimitri Semizarov, Brendan Healy, Joseph S. Doyle, John F. Dillon
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 55(12)
Conventional healthcare models struggle to engage those at risk of hepatitis C virus (HCV) infection. This international study evaluated point-of-care (PoC) HCV RNA diagnostic outreach and direct-acting antiviral (DAA) treatment for individuals recei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::410e497816c3d74a03a1935c5e5c4dc4
https://pubmed.ncbi.nlm.nih.gov/35538396
https://pubmed.ncbi.nlm.nih.gov/35538396